Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
OA03 - Systemic Therapies for SCLC: Novel Targets and Patients' Selection
- 13:30 - 15:00
- 9/08/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Oral Session
- Track: Small Cell Lung Cancer/NET
- Moderators:Christine Lee Hann, Makoto Nishio
-
+
OA03.01 - A Non-Randomized, Open-Label, Prospective, Multicenter Study of Apatinib as Second-Line and Later-Line Therapy in Patients with ES-SCLC
13:30 - 13:40 | Presenter: Quan Liu | Author(s): Dong Hua, Junying Xu, Yehong Xu, Meng Chen, Lichun Deng, Jianping Wu, Tong Zhou, Liqin Zhang, Jie Tan, Xingxiang Pu, Yulong Shang, Jun Hua, Yuanqin Li, Wei Cai, Yulan Gu, Xingchen Peng
- Abstract
Loading... -
+
OA03.02 - Effect of Anlotinib in Advanced Small Cell Lung Cancer Patients Previously Received Chemoradiotherapy: A Subgroup Analysis in ALTER 1202 Trial
13:40 - 13:50 | Presenter: Qiming Wang | Author(s): Ying Cheng, Kai Li, Jianhua Shi, Baohui Han, Lin Wu, Gongyan Chen, Jianxing He, Jie Wang, Haifeng Qin, Xiao-Ling Li
- Abstract
Loading... -
+
OA03.03 - Initial Efficacy and Safety Results of Irinotecan Liposome Injection (nal-IRI) in Patients with Small Cell Lung Cancer
13:50 - 14:00 | Presenter: Luis Paz-Ares | Author(s): David R Spigel, Yuanbin Chen, Maria Jove, Oscar Juan, Patricia Rich, Theresa Hayes, Vanesa Gutiérrez Calderón, Reyes Bernabe, Alejandro Navarro, Afshin Dowlati, Bin Zhang, Yan Moore, Tiffany Wang, Natalya Nazarenko, Santiago Ponce, Paul A Bunn, Jr
- Abstract
Loading... -
+
OA03.04 - Discussant - OA03.01, OA03.02, OA03.03
14:00 - 14:15 | Presenter: Flavia Amaral Duarte
- Abstract
No abstract available for this presentation
-
+
OA03.05 - Characterization of Genomic Alterations in Chinese LCNEC and SCLC via Comprehensive Genomic Profiling
14:15 - 14:25 | Presenter: Lin Wu | Author(s): Liming Cao, Likun Chen, Bo Zhu, Xiaohua Hu, Gen Lin, Yingcheng Lin, Sheng Zhang, Wenying Peng, Meilin Jiang, Xinru Mao, Tengfei Zhang, Junyi Ye, Lu Zhang
- Abstract
Loading... -
+
OA03.06 - ASCL1, NEUROD1, and POU2F3 Drive Distinct Subtypes of Small Cell Lung Cancer with Unique Therapeutic Vulnerabilities
14:25 - 14:35 | Presenter: Carl M. Gay | Author(s): Lixia Diao, C. Allison Stewart, Yuanxin Xi, Robert J. Cardnell, Stephen Swisher, Jack Roth, Bonnie Glisson, Jing Wang, John Victor Heymach, Lauren Averett Byers
- Abstract
Loading... -
+
OA03.07 - Immune-Related Adverse Events and Clinical Outcome to Anti PD-1 Axis Inhibition in SCLC: A Multicenter Retrospective Analysis
14:35 - 14:45 | Presenter: Biagio Ricciuti | Author(s): abdul rafeh Naqash, Brian Henick, Deepa Rangachari, Jarushka Naidoo, Deepti Venkatraman, Giuseppe Lamberti, Gonzalo Recondo Jr., Jiajia Zhang, Shravanti Macherla, Sameer Baig, Paul Raymond Walker, Kartik Sehgal, Renato Umeton, Lynette M Sholl, Naiyer A Rizvi, Daniel B Costa, Mark Awad
- Abstract
Loading... -
+
OA03.08 - Discussant - OA03.05, OA03.06, OA03.07
14:45 - 15:00 | Presenter: Herbert H. Loong
- Abstract
No abstract available for this presentation
-
+
YI04 - Basics of Immunology
- 13:30 - 15:00
- 9/08/2019
- Location: Dublin (1997)
- IASLC CME Accredited
- Type: Young Investigator Session
- Track: Young Investigators
- Moderators:Noemi Reguart, Julie R Brahmer
-
+
YI04.01 - PD-L1: Basics of Biology
13:30 - 13:50 | Presenter: Ignacio Gil-Bazo
- Abstract
No abstract available for this presentation
-
+
YI04.02 - Immuno-Oncology Trials: Other Endpoints Needed?
13:50 - 14:10 | Presenter: Martin Reck
- Abstract
Loading... -
+
YI04.03 - The Place of Immunotherapy in NSCLC Therapeutic Algorythm
14:10 - 14:30 | Presenter: Rolf Stahel
- Abstract
Loading... -
+
YI04.04 - How to Select Patients for Immunotherapy
14:30 - 14:50 | Presenter: Naiyer A Rizvi
- Abstract
Loading... -
+
YI04.05 - Q&A
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
ES11 - Lung Cancer Plasticity and Drug Resistance
- 15:15 - 16:45
- 9/08/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Educational Session
- Track: Biology
- Moderators:Luca Roz, Nagahiro Saijo
-
+
ES11.01 - Lung Adenocarcinoma to Squamous Cell Carcinoma Transdifferentiation and Drug Resistance
15:15 - 15:25 | Presenter: Hongbin Ji
- Abstract
Loading... -
+
ES11.02 - SCLC Lineage Transformation in Lung Adenocarcinoma and Resistance to Targeted Therapies
15:25 - 15:35 | Presenter: William Lockwood | Author(s): Yusuke Inoue
- Abstract
Loading... -
+
ES11.03 - Immunotherapy and Endogenous Retroviruses in Small-Cell Lung Cancer
15:35 - 15:45 | Presenter: Israel Canadas
- Abstract
Loading... -
+
ES11.04 - Mechanisms for Resistance to TKI and ICI
15:45 - 15:55 | Presenter: Katerina Politi
- Abstract
Loading... -
+
ES11.05 - MSK-IMPACT, a Hospital Based Genetic Screening Using FDA-Approved NGS System
15:55 - 16:05 | Presenter: Alexander Drilon
- Abstract
Loading... -
+
ES11.06 - Toxicology of Tobacco and Metabolites, and Impact on Cancer
16:05 - 16:15 | Presenter: Maciej L. Goniewicz
- Abstract
Loading... -
+
ES11.07 - Q&A
16:15 - 16:45
- Abstract
No abstract available for this presentation
-
+
ES12 - Lung Cancer Pathology in the Age of Genomics
- 15:15 - 16:45
- 9/08/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Educational Session
- Track: Pathology
- Moderators:Masayuki Noguchi, Beatriz Bellosillo
-
+
ES12.01 - Multiple Lung Nodules
15:15 - 15:30 | Presenter: Sanja Dacic
- Abstract
Loading... -
+
ES12.02 - Invasive Mucinous Adenocarcinoma
15:30 - 15:45 | Presenter: Yasushi YATABE
- Abstract
Loading... -
+
ES12.03 - Tumor Heterogeneity
15:45 - 16:00 | Presenter: Wendy Cooper
- Abstract
Loading... -
+
ES12.04 - Machine Learning and Integrative Multi-Omics Analysis Identify Novel Molecular Groups of Lung Neuroendocrine Tumors
16:00 - 16:15 | Presenter: Lynnette Fernandez-Cuesta
- Abstract
Loading... -
+
ES12.05 - Impact of STAS in Lung Cancer Staging
16:15 - 16:30 | Presenter: William D. Travis | Author(s): Rania G. Aly, Takashi Eguchi, Natasha Rekhtman, Yukako Yagi, Prasad S Adusumilli
- Abstract
Loading... -
+
ES12.06 - Q&A/Poll
16:30 - 16:45
- Abstract
No abstract available for this presentation
-
+
ES13 - Global Political, Legal, and Financial Strategies For Tobacco Control
- 15:15 - 16:45
- 9/08/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Educational Session
- Track: Prevention and Tobacco Control
- Moderators:Desmond Carney, Esteve Fernandez
-
+
ES13.01 - Tobacco Cessation and Cancer Patients
15:15 - 15:30 | Presenter: Esteve Fernandez | Author(s): Cristina Martínez
- Abstract
Loading... -
+
ES13.02 - Pursuing Criminal Charges Against Big Tobacco
15:30 - 15:45 | Presenter: Wanda De Kanter
- Abstract
Loading... -
+
ES13.03 - Foundation for a Smoke Free Future: Funding Opportunities or Smoke Screen for the Tobacco Industry?
15:45 - 16:00 | Presenter: Emily Stone
- Abstract
Loading... -
+
ES13.04 - Comparing ENDS to NRT for Smoking Cessation
16:00 - 16:15 | Presenter: Hayden McRobbie
- Abstract
Loading... -
+
ES13.05 - Stigma and Impact of Tobacco Control Policy
16:15 - 16:30 | Presenter: Andrea Borondy Kitts
- Abstract
Loading... -
+
ES13.06 - Q&A
16:30 - 16:45
- Abstract
No abstract available for this presentation
-
+
ES14 - What First Line in Oncogene Addicted NSCLC
- 15:15 - 16:45
- 9/08/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Educational Session
- Track: Targeted Therapy
- Moderators:Dolores Isla, Jessica Menis
-
+
Introduction/Poll
15:15 - 15:15
- Abstract
No abstract available for this presentation
-
+
ES14.01 - First Line in EGFR Mutated Patients
15:15 - 15:30 | Presenter: Thanyanan Reungwetwattana
- Abstract
Loading... -
+
ES14.02 - First Line in ALK Translocated Patients
15:30 - 15:45 | Presenter: Alice T. Shaw
- Abstract
Loading... -
+
ES14.03 - First Line in ROS1 Translocated Patients
15:45 - 16:00 | Presenter: Frances Shepherd
- Abstract
No abstract available for this presentation
-
+
ES14.04 - First Line for Rare Mutations (RET, BRAF, HER2)
16:00 - 16:15 | Presenter: David Planchard
- Abstract
Loading... -
+
ES14.05 - Patients Harbouring a Driven-Mutation: Pro and Patient's Perspective
16:15 - 16:30 | Presenter: Karen L Reckamp
- Abstract
Loading... -
+
ES14.06 - Q&A
16:30 - 16:45
- Abstract
No abstract available for this presentation
-
+
GR02 - Improving Patients Quality of Life During Treatment of Metastatic Disease
- 15:15 - 16:45
- 9/08/2019
- Location: Interlaken (1988)
- IASLC CME Accredited
- Type: Grand Rounds Session
- Track: Advanced NSCLC
- Moderators:Eduardo Richardet, Jesús González Barboteo, Manuel Dómine
-
+
Introduction/Poll
15:15 - 15:15
- Abstract
No abstract available for this presentation
-
+
GR02.01 - How Can We Incorporate Exercise Practices into Patient's Lives?
15:15 - 15:35 | Presenter: Clarissa Mathias
- Abstract
Loading... -
+
GR02.02 - What is the Best Management of Targeted Therapy Toxicity?
15:35 - 15:55 | Presenter: Glenwood D. Goss
- Abstract
Loading... -
+
GR02.03 - What Is the Best Management of Immunotherapy Toxicity?
15:55 - 16:15 | Presenter: Jean-Marie Michot
- Abstract
Loading... -
+
GR02.04 - Immunotherapy: Hyperprogression and Treatment Beyond Progression
16:15 - 16:35 | Presenter: David R Gandara
- Abstract
Loading... -
+
GR02.05 - Q&A
16:35 - 16:45
- Abstract
No abstract available for this presentation
-
+
MA08 - Pawing the Way to Improve Outcomes in Stage III NSCLC
- 15:15 - 16:45
- 9/08/2019
- Location: Tokyo (1982)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Treatment of Locoregional Disease - NSCLC
- Moderators:Simon Ekman, Helena A Yu
-
+
MA08.01 - Analysis of PD-L1 Expression on Circulating Stromal and Tumor Cells in Lung Cancer Patients Treated with Chemoradiation Therapy and Atezolizumab
15:15 - 15:20 | Presenter: Steven H Lin | Author(s): Alexander Augustyn, Jianzhong He, Yawei Qiao, Zhongxing Liao, Ashvathi Raghavakaimal, Kirby Gardner, John Victor Heymach, Anne Tsao, Daniel Adams
- Abstract
Loading... -
+
MA08.02 - Durvalumab Impact in the Treatment Strategy of Stage III Non-Small Cell Lung Cancer (NSCLC): An EORTC Young Investigator Lung Cancer Group Survey
15:20 - 15:25 | Presenter: Matteo Giaj Levra | Author(s): Justin Benet, Baktiar Hasan, Thierry Berghmans, Alessio Bruni, Anne Marie Clasina Dingemans, Niccolo' Giaj Levra, John G Edwards, Corinne Faivre-Finn, Nicolas Girard, Elisa Gobbini, Laurent Greillier, Lizza Hendriks, Sylvie Lantuejoul, Antonin Levy, Silvia Novello, Mary O'Brien, Martin Reck, Alessia Pochesci, Jessica Menis, Benjamin Besse
- Abstract
Loading... -
+
MA08.03 - Adjuvant Pembrolizumab in N2 Positive NSCLC Treated with Concurrent Chemoradiotherapy Followed by Surgery: Phase II, Prospective Study
15:25 - 15:30 | Presenter: Sehhoon Park | Author(s): Hyun Ae Jung, Jong Ho Cho, Jong-Mu Sun, Hong Kwan Kim, Se-Hoon Lee, Yong Soo Choi, Jin Seok Ahn, Jhingook Kim, Keunchil Park, Jae Ill Zo, Young Mog Shim, Myung-Ju Ahn
- Abstract
Loading... -
+
MA08.04 - Discussant - MA08.01, MA08.02, MA08.03
15:30 - 15:45 | Presenter: Delvys Rodriguez-Abreu
- Abstract
No abstract available for this presentation
-
+
MA08.05 - A Multi-Center Analysis of Right vs Left-Sided Pneumonectomy Following Induction Therapy
15:45 - 15:50 | Presenter: Chi-Fu Jeffrey Jeffrey Yang | Author(s): Nicholas R Mayne, Athar Battoo, Sai Yendamuri, Todd Demmy, Robert McKenna, Thomas A D’amico, Mark Berry
- Abstract
Loading... -
+
MA08.06 - Perioperative Outcomes of Lung Cancer Patients with Interstitial Pneumonia
15:50 - 15:55 | Presenter: Aki Katarina Kobayashi | Author(s): Yu Okubo, Masaya Yotsukura, Yukihiro Yoshida, Kazuo Nakagawa, Noriko Motoi, Shun-ichi Watanabe
- Abstract
Loading... -
+
MA08.07 - The Concordance Between Patient Reported Outcomes and Clinician Reported Outcomes During Radiotherapy in Lung Cancer Patients
15:55 - 16:00 | Presenter: Evalien Veldhuijzen | Author(s): Iris Walraven, Margriet Kwint, Laura Roose, José Belderbos, Tomas Janssen
- Abstract
Loading... -
+
MA08.08 - Discussant - MA08.05, MA08.06, MA08.07
16:00 - 16:15 | Presenter: Norihiko Ikeda
- Abstract
No abstract available for this presentation
-
+
MA08.09 - Results of Trimodality Therapy for Patients with cN2 Lung Cancer Diagnosed by Video-Assisted Mediastinoscopic Lymphadenectomy (VAMLA)
16:15 - 16:20 | Presenter: Sergi Call | Author(s): Carme Obiols, Ramon Rami-Porta, Silvia Catot, Miriam Nuñez, Marc Campayo, Francisco Perez Ochoa, Mireia Serra-Mitjans, Jose Belda-Sanchis
- Abstract
Loading... -
+
MA08.10 - Early and Late Outcomes After Surgery for pT4 NSCLC Reclassified by AJCC 8th Edition Criteria
16:20 - 16:25 | Presenter: Jack G Mouhanna | Author(s): Amit Katz, Pierre O Fiset, Roni F Rayes, Aya Siblini, Emma Lee, Andrew Seely, Christian Sirois, David Mulder, Jonathan Cools-Lartigue, Lorenzo E. Ferri, Jonathan D. Spicer
- Abstract
Loading... -
+
MA08.11 - SLCG SCAT Trial: Surgical Audit to Lymph Node Assessment Based on IASLC Recommendations
16:25 - 16:30 | Presenter: Jose Ramon Jarabo Sarceda | Author(s): SERGIO Bolufer, Roberto Mongil, Pedro Lopez De Castro, RAMON Moreno, JUAN CARLOS PeÑalver, Raúl Embún, Joaquín Pac, Francisco Javier Algar, Pablo Gámez, Marcelo Jiménez, Gabriel Sales, Eva Pereira, Bartomeu Massuti, Mariano Provencio, Florentino Hernando-Trancho
- Abstract
Loading... -
+
MA08.12 - Discussant - MA08.09, MA08.010, MA08.11
16:30 - 16:45 | Presenter: Leah Backhus
- Abstract
No abstract available for this presentation
-
+
MA09 - EGFR & MET
- 15:15 - 16:45
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Jordi Remon, Juergen Wolf
-
+
MA09.01 - A Phase I/II Trial of Dasatinib and Osimertinib in TKI Naïve Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
15:15 - 15:20 | Presenter: Chul Kim | Author(s): Stephen V. Liu, Jeanette Crawford, Deepa S Subramaniam, Guiseppe Giaccone
- Abstract
Loading... -
+
MA09.02 - In Vivo, Ex Vivo and Early Clinical Activity of EGFR Monoclonal Antibody and Osimertinib in EGFR Exon 20 Insertion NSCLC
15:20 - 15:25 | Presenter: Jonathan Wesley Riess | Author(s): Nicolas Floch, Philip C. Mack, Matthew J. Martin, Daniel Vang, Paul D. Smith, Darren Cross, Mingshan Cheng, James Keck, Susan Groshen, Michael Rabin, Sukhmani Padda, Geoffrey R Oxnard, Jacob Sands, Kavitha Ramchandran, Mariana Koczywas, Jeffrey A. Moscow, Pasi A Jänne, Primo N. Lara, Edward Newman, David R Gandara
- Abstract
Loading... -
+
MA09.03 - Identification of Mechanisms of Acquired Resistance to Poziotinib in EGFR Exon 20 Mutant Non-Small Cell Lung Cancer (NSCLC)
15:25 - 15:30 | Presenter: Jacqulyne Ponville Robichaux | Author(s): Yasir Elamin, Brett Carter, Mehmet Altan, Don Lynn Gibbons, Frank Fossella, George R Simon, Vincent Lam, George Blumenschein Jr, Anne Tsao, Jonathan Kurie, Frank E Mott, Marcelo Vailati Negrao, Limei Hu, Junqin He, Monique Nilsson, Brent Roeck, Zane Yang, Vassiliki A Papadimitrakopoulou, John Victor Heymach
- Abstract
Loading... -
+
MA09.04 - Discussant - MA09.01, MA09.02, MA09.03
15:30 - 15:45 | Presenter: Juergen Wolf
- Abstract
No abstract available for this presentation
-
+
MA09.05 - Genomic Correlates of Differential Response to EGFR-Directed Tyrosine Kinase Inhibitors
15:45 - 15:50 | Presenter: Natalie Vokes | Author(s): Tom Nguyen, Christine A Lydon, Emily Chambers, Lynette M Sholl, Mizuki Nishino, Eliezer M Van Allen, Pasi A Jänne
- Abstract
Loading... -
+
MA09.06 - Adaptive Mechanisms of Resistance to Targeted Therapy in EGFR Mutant Brain Metastasis
15:50 - 15:55 | Presenter: Don X. Nguyen | Author(s): Sally Adua, Minghui Zhao, Darren Cross, Paul Smith
- Abstract
Loading... -
+
MA09.07 - Activity of Larotrectinib in TRK Fusion Lung Cancer
15:55 - 16:00 | Presenter: Anna F Farago | Author(s): Shivaani Kummar, Victor Moreno, Jyoti D Patel, Ulrik Lassen, Lee Rosen, Nora C. Ku, Michael C. Cox, Shivani Nanda, Barrett H. Childs, David M. Hyman, Alexander Drilon
- Abstract
Loading... -
+
MA09.08 - Discussant - MA09.05, MA09.06, MA09.07
16:00 - 16:15 | Presenter: Ana Vivancos
- Abstract
No abstract available for this presentation
-
+
MA09.09 - Long-Term Outcomes to Tepotinib Plus Gefitinib in Patients with EGFR-Mutant NSCLC and MET Dysregulation: 18‑Month Follow-Up
16:15 - 16:20 | Presenter: Yi-Long Wu | Author(s): Ying Cheng, Jianying Zhou, Shun Lu, Yiping Zhang, Jun Zhao, Dong-Wan Kim, Ross Soo, Sang-we Kim, Hongming Pan, Yuh-Min Chen, Chih-Feng Chian, Xiaoqing Liu, Daniel SW Tan, Rolf Bruns, Josef Straub, Andreas Johne, Jürgen Scheele, Keunchil Park, James Chih-Hsin Yang
- Abstract
Loading... -
+
MA09.10 - Comprehensive Analysis of Secondary Mutation as Resistance Mechanism to Seven MET-TKIs for MET Exon 14 Skipping in Vitro
16:20 - 16:25 | Presenter: Toshio Fujino | Author(s): Yoshihisa Kobayashi, Kenichi Suda, Takamasa Koga, Masaya Nishino, Shuta Ohara, Masato Chiba, Akira Hamada, Toshiki Takemoto, Junichi Soh, Tetsuya Misudomi
- Abstract
Loading... -
+
MA09.11 - Mechanisms of Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14 Mutant Non-Small Cell Lung Cancer
16:25 - 16:30 | Presenter: Gonzalo Recondo Jr. | Author(s): Magda Bahcall, Lynette M Sholl, Giulia Constanza Leonardi, Biagio Ricciuti, Tom Nguyen, Deepti Venkatraman, Giuseppe Lamberti, Renato Umeton, Pasi A Jänne, Mark Awad
- Abstract
Loading... -
+
MA09.12 - Discussant - MA09.09, MA09.010, MA09.11
16:30 - 16:45 | Presenter: Ravi Salgia
- Abstract
No abstract available for this presentation
-
+
MA10 - Emerging Technologies for Lung Cancer Detection
- 15:15 - 16:45
- 9/08/2019
- Location: Dublin (1997)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Screening and Early Detection
- Moderators:Fabrizio Bianchi, Marcelo Sanchez
-
+
MA10.01 - Invasive Adenocarcinoma in Screen Detected Pure Ground-Glass Nodules (GGN)
15:15 - 15:20 | Presenter: Renelle Myers | Author(s): John English, Sukhinder Kaur Atkar-Khattra, John Mayo, John Yee, Annette Maree McWilliams, Ming Sound Tsao, Stephen Lam
- Abstract
Loading... -
+
- Abstract
Loading... -
+
MA10.03 - Quantitative Computed Tomography (CT) Based Texture Analysis; Could We Predict the Future Growth of the Pure Ground Glass Nodules?
15:25 - 15:30 | Presenter: Joosung Sun | Author(s): Hye Lin Kim, SeulGi You, Youngin Choi, Young Gi Min, Kyung Joo Park
- Abstract
Loading... -
+
MA10.04 - Discussant - MA10.01, MA10.02, MA10.03
15:30 - 15:45 | Presenter: Marcelo Sanchez
- Abstract
No abstract available for this presentation
-
+
MA10.05 - Breath Analysis: New Key-Challenges for Early Detection of Lung and Pleural Neoplasms
15:45 - 15:50 | Presenter: Annamaria Catino | Author(s): Gianluigi De Gennaro, Alessia Di Gilio, Laura Facchini, Domenico Galetta, Teresa Mongelli, Jolanda Palmisani, Francesca Porcelli, Niccolò Varesano, Pamela Pizzutilo, Michele Montrone, Vito Longo, Gabriella Del Bene, Angelica Mastrandrea, Francesco Pesola, Donata Ricci, Patrizia Petrillo, Antonella Zacheo
- Abstract
Loading... -
+
MA10.06 - Randomized Clinical Trial with Computer Assisted Diagnosis (CAD) Versus Radiologist as First Reader of Lung Screening LDCT
15:50 - 15:55 | Presenter: Ren Yuan | Author(s): John Mayo, Isaac Streit, Sukhinder Kaur Atkar-Khattra, Renelle Myers, John Yee, Stephen Lam
- Abstract
Loading... -
+
MA10.07 - Integrative Analysis of Epistasis Involving Oncogenesis-Related Genes in Lung Cancer Risk Development
15:55 - 16:00 | Presenter: Yafang Li | Author(s): Xiangjun Xiao, Yohan Bossé, Younghun Han, Christopher Ian Amos
- Abstract
Loading... -
+
MA10.08 - Discussant - MA10.05, MA10.06, MA10.07
16:00 - 16:15 | Presenter: Fabrizio Bianchi
- Abstract
No abstract available for this presentation
-
+
MA10.09 - Evaluation of the Clinical Utility of the PanCan, EU-NELSON and Lung-RADS Protocols for Management of Screen Detected Lung Nodules at Baseline
16:15 - 16:20 | Presenter: Renelle Myers | Author(s): John Mayo, Martin Tammemagi, Sukhinder Kaur Atkar-Khattra, Ren Yuan, John Yee, John English, Kyle Grant, Alexandar Lee, Anna McGuire, Annette Maree McWilliams, Fraser Brims, Lin Mo, Stephen Lam
- Abstract
Loading... -
+
MA10.10 - Uptake in Lung Cancer Screening – Does CT Location Matter? A Pilot Study Comparison of a Mobile and Hospital Based CT Scanner
16:20 - 16:25 | Presenter: Emily Bartlett | Author(s): Samuel Kemp, Sujal Desai, Saeed Mirsadraee, Carole Ridge, Jaymin Morjaria, Pallav Shah, Katie Morris, Jane Derbyshire, Michelle Chen, Christine Peacock, Natallia Ivashniova, Maria Martins, James Addis, Simon Padley, Anand Devaraj
- Abstract
Loading... -
+
MA10.11 - Sensitivity and Optimal Clinicopathological Features of Genetic Targeted Liquid Biopsy in pN0M0 Lung Adenocarcinoma
16:25 - 16:30 | Presenter: Masaoki Ito | Author(s): Yoshihiro Miyata, Shoko Hirano, Fumiko Irisuna, Naoto Kishi, Yasuhiro Tsutani, Rafael Rosell, Morihito Okada
- Abstract
Loading... -
+
MA10.12 - Discussant - MA10.09, MA10.10, MA10.11
16:30 - 16:45 | Presenter: Christine Dorothy Berg
- Abstract
No abstract available for this presentation